A first-of-its-kind study tested the safety of psilocybin and found that patients experienced clinically significant ...

Another quasi-experimental study -- this one using Australian records -- showed that being eligible for a herpes zoster ...

25, 2025 — Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein ... treatments for a range of psychiatric and neurological disorders attributed to ...

Two small studies published recently in Nature offer early, but important validation that stem cell treatments for Parkinson’s disease are viable.

The results indicate that "now we have the potential to really, really halt this disease in its tracks," says Dr. Mya Schiess ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor symptoms associated with Parkinson’s disease.

Parkinson's disease is a common neurological disorder, and April is widely recognized as Parkinson’s Awareness Month. The ...

A phase I/II trial showed that transplanting dopaminergic progenitors derived from induced pluripotent stem cells was safe in ...

Israeli researchers said Friday they have developed a simple, "revolutionary" blood test that for the first time would allow ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

Two small studies published recently in Nature offer early, but important validation that stem cell treatments for Parkinson’s disease are viable.